« Back
Home /
AP24534 50mg

AP24534 50mg

Item no.	A10080-50
Manufacturer	Adooq
CASRN	943319-70-8
Amount	50 mg
Quantity options	10 mg 100 mg 10mM x 1mL in DMSO 200 mg 25 mg 5 mg 50 mg
Category	Cardiovascular Research Thrombosis & Hemostasis Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	>98%
Smiles	CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Ponatinib
Similar products	AP24534
Available
Storage Conditions	2 years at -20C
Molecular Weight	532, 6
Chemical Name	3-(2-Imidazo[1, 2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-benzamide
Description	AP24534 (Ponatinib) is a potent multi-kinase and pan-BCR-ABL inhibitor.
Solubilty	DMSO

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 50 mg

available

Delivery expected until 8/7/2025

Compare

Add to wishlist

Get an offer

Request delivery time